Single-cell proteomics breakthroughs reveal protein diversity in early embryos and tumors

Over the past decade, single-cell proteomics has moved from speculation to practical application, now allowing scientists to profile thousands of proteins in a single cell. In 2025, a study showed that the two initial mouse embryo cells—named alpha and beta—already exhibit divergent protein profiles that predict their future roles, with beta cells favoring healthy embryonic development. Parallel work demonstrates that tumor cells hidden within complex microenvironments can be distinguished by their protein makeup, offering clues to patient outcomes.

Technological strides such as the SCoPE-MS workflow, nanoPOTS chips, the SciProChip, and high-end Orbitrap Astral and timsTOF Ultra mass spectrometers have driven sensitivity and coverage upward, though equipment costs can exceed $1 million and daily sample throughput remains low. Multiplexed labeling and refined preparation protocols improve data quality but add complexity. Despite these hurdles, the field is rapidly expanding, with labs worldwide adopting devices like Cellenion's cellenONE for precise cell isolation.